Flosonics Medical's wearable ultrasound device, FloPatch, has been deployed at The Mount Sinai Hospital in its surgical and transplant ICUs.
This marks Flosonics' first East Coast deployment, highlighting the increasing demand for real-time, personalized fluid management in intensive care units.
FloPatch allows rapid, non-invasive hemodynamic assessments, providing real-time blood flow data at the bedside for IV fluid management.
The device enables clinicians to identify fluid responsiveness in under three minutes, helping avoid unnecessary fluid administration.
42% of patients assessed using FloPatch at Mount Sinai were found to be unresponsive to fluids, leading to more personalized treatment decisions.
Dr. John Oropello from Mount Sinai highlighted the device's role in making timely, personalized decisions in critical care situations.
By adopting FloPatch, Mount Sinai is embracing precision medicine in ICU care, moving towards individualized treatment instead of standardized fluid therapy.
Flosonics Medical aims to support this shift by providing clinicians with tools for smarter and safer interventions.
FloPatch streamlines hemodynamic assessments, offering a more accessible and repeatable method for critical care.